First drug to treat Alexander disease approved by the FDA after three decades of research

The Food and Drug Administration precocious approved the archetypal cause to dainty Alexander disease, a rare, progressive and often fatal neurological upset that tin impact motor, cognitive and autonomic functions similar bosom complaint and breathing. The drug, Zanvastro, is the archetypal and lone disease-modifying attraction for Alexander disease. Until now, attraction of the illness has been constricted to grounds management.